CS Pramesh discusses ten low-value or harmful practises that should be avoided in cancer care in India.

Choosing Wisely India

Bianca Hoeben discusses the latest guidelines from the SIOPE radiotherapy working group on vertebral radiotherapy dose in paediatric patients.

Paediatric vertebral radiotherapy

Anna Bibby joins The Lancet Oncology to discuss recent developments in the treament of malignant plural mesothelioma.

Malignant plural mesothelioma

Frederick Locke joins The Lancet Oncology to discuss long-term results from the ZUMA-1 trial on the safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma.

CAR T-cell therapy

Talía Malagón discusses her modelling study which assesses the age at which to stop cervical cancer screening in older women and the remaining lifetime risk of cervical cancer.

Cervical cancer screening in older women

Stein Kaasa and Jon Loge discuss their new Commission on palliative care.

Palliative care in oncology

Andre Ilbawi talks about his global analysis of available national cancer control plans with The Lancet Oncology.

Global review of cancer control

A review in The Lancet Oncology asks whether patient reported outcomes in RCTs are consistent across their analysis, reporting, and interpretation. Author Madeline Pe discusses the findings.

Are patient reported outcomes consistent?

Eva Steliarova-Foucher joins The Lancet Oncology to discuss the Europe-wide Automated Childhood Cancer Information System, and the increase in cancer incidence rates among children and adolescents.

Changing incidence of adolescent cancer

The Lancet Oncology is a monthly journal, renowned for the publication of high-quality peer reviewed research, reviews and analysis in cancer from around the world. In the monthly podcasts, editors of the journal discuss highlights of the current issue.

Listen to The Lancet Oncology

Samra Turajlic discusses the contribution of small insertions and deletions to tumour-specific antigen analyses.

Indel derived tumour-specific neoantigens: The Lancet Oncology: Aug 2017

Mark Souweidane joins The Lancet Oncology to discuss his dose-escalation study, assessing a convection-enhanced delivery for diffuse intrinsic pontine glioma.

Diffuse intrinsic pontine glioma

Bo Jan Noordman joins The Lancet Oncology to discuss the findings from his study of residual disease detection in oesophageal cancer.

Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer

Fabio Conforti talks to The Lancet Oncology about a meta-analysis showing that a patient's sex can affect the efficacy of cancer immunotherapy.

Gender and cancer immunotherapy efficacy

Paul Kluetz from the US FDA discusses the issues surrounding the use of patient-reported outcomes in regulatory decision making.

PROs in regulatory decision making

Michael Hoeckel joins The Lancet Oncology to discuss his latest trial on the surgical treatment of vulvar carcinoma based on the theory of ontogenetic cancer fields.

Vulvar field resection

Håvard Emil Danielsen joins The Lancet Oncology to discuss his latest paper on machine learning algorithms to analyse chromatin organisation as a prognostic marker for cancer.

Chromatin organisation and cancer prognosis

Ross Camidge discusses RANO's papers on clinical trial design for patients with brain metastases.

Trial design for brain metastases: The Lancet Oncology: Jan 2018

John Field discusses a European position statement on lung cancer screening using low-dose CT.

Lung cancer screening: The Lancet Oncology: November 27, 2017

Commission co-chairs Chi Van Dang and Elizabeth M. Jaffee discuss a new Lancet Oncology Commission on cancer treatment and care in the USA.

Future cancer research priorities in the USA: The Lancet Oncology Commission: October 31, 2017

Ricky Sharma discusses results from three prospective trials on the use of selective internal radiotherapy for liver metastases from colorectal cancer.

Selective internal radiotherapy for colorectal cancer: The Lancet Oncology: September 2017

Percy Lee discusses the impact of prior radiotherapy on the efficacy of pembrolizumab when used to treat non-small cell lung cancer.

Prior radiotherapy and pembrolizumab: The Lancet Oncology: June 28, 2017

Martin Taphoorn outlines the importance of palliative care for patients with gliomas.

EANO and palliative care: The Lancet Oncology: June 2, 2017

Sandro Porceddu discusses the new Lancet Oncology Series on head and neck cancer.

 

Head and neck cancer Series: The Lancet Oncology: April 26, 2017

Michele Cavo discusses the International Myeloma Working Group’s recommendations on the use of 18F-FDG PET/CT for patients with multiple myeloma and other plasma cell dyscrasias.

18F-FDG PET/CT for multiple myeloma: The Lancet Oncology: April, 2017

Lesley Seymour discusses the iRECIST guidelines for assessing tumour responses in immunotherapy trials.

Response assessment criteria for immunotherapy drugs: The Lancet Oncology: March 2017

The best podcasts on investing. For anyone interested in the stories in the investing industry, whether it's an interview with Ray Dalio or Ed Thorp to the writer of The Big Short. This topic includes the most fascinating stories from all the best investors. Add episodes you're interested into your queue below!

Best Investing Podcasts

The best philosophy podcast episodes. Asking questions about how to live a better life, what it means to be and do good, to the idea of God. This topic includes episodes that bring about important questions that everyone should be asking themselves. Add episodes you're interested into your queue below!